Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GT20029 shows promising results for hair loss treatment, with potential approval in China by 2026 or 2027, but U.S. approval may take longer. It could serve as an alternative to finasteride, with a potentially better side effect profile.

PP405 is discussed as a potential hair loss treatment, but its effectiveness and safety are uncertain. Some users express skepticism, while others are hopeful, comparing it to existing treatments like Minoxidil and Finasteride.

A user started taking 1mg of finasteride daily but experienced anxiety and brain fog, considering reducing the dose to 0.5mg to adjust. They seek advice on whether this change could help manage side effects and hair shedding.

A 25-year-old male has been using oral finasteride and minoxidil for six months without noticeable progress in hair regrowth and is considering switching to dutasteride or a hair transplant. Users suggest giving the treatment more time, adding microneedling, and possibly using topical minoxidil.

A 26-year-old is considering switching from a regimen of minoxidil, finasteride, and RU58841 to possibly include pyrilutamide due to insufficient results in slowing hair loss. They are seeking advice on whether to add pyrilutamide or replace RU58841 with it, considering cost and effectiveness.

Combining minoxidil with tretinoin appears to enhance hair growth for some users, with several reporting better results than using minoxidil alone. Some users also incorporate other treatments like dutasteride, latanoprost, and microneedling for improved outcomes.

A user shared their 3-year progress using 0.5mg finasteride daily for hair loss, reporting no side effects and significant improvement after 8-10 months. They are considering increasing the dosage or adding minoxidil for further results.

A 20-year-old experiencing diffuse thinning is using a regimen of oral minoxidil, dutasteride, finasteride, and ketoconazole to address hair loss. They are considering increasing the minoxidil dosage or adding topical treatments due to minimal shedding observed after 16 days.

A new alcohol-free, propylene glycol-free topical finasteride foam is available for prescription in Canada and the USA, offering a cleaner alternative for hair loss treatment. The product also offers a combination of 0.1% finasteride with 5% minoxidil and aims to be affordable and less irritating for sensitive scalps.

Tips for using a scalp applicator for Minoxidil, including using smaller doses for even coverage, twisting the applicator for better distribution, adjusting pressure to control flow, and cleaning regularly. Users also discuss alternative methods like pipettes, q-tips, and spray bottles for applying Minoxidil, especially for those with longer or thicker hair.

Dutasteride and oral minoxidil are commonly used in Spain for hair loss, with a typical dose of 0.5 mg dutasteride and 2.5-5 mg oral minoxidil. Some users report side effects like erectile dysfunction when using finasteride and minoxidil.

A user is considering using homemade hair sprays with ingredients like fenugreek seeds, rosemary, and lavender to promote hair growth, alongside topical minoxidil. Other users suggest that while these sprays may improve hair health, they are not as effective as minoxidil and finasteride for regrowing hair, and recommend using proven treatments like finasteride for better results.

The conversation discusses the potential updates on the pp405 trial for hair loss, with completion expected by December 2025. Participants express skepticism about new treatments, suggesting continued use of finasteride, while others hope for innovative solutions beyond current medications.

The user is using biotin, pumpkin seed oil, saw palmetto, green tea, Minoxidil, Nizoral shampoo, and derma rolling to combat hair loss but is hesitant to use finasteride due to potential side effects. Others suggest that without finasteride or dutasteride, the natural approach is unlikely to be effective long-term.

The conversation discusses the potential effectiveness and future results of the hair loss treatment pp405, with questions about its impact on different hair loss stages and areas. There is anticipation for phase 3 trial results to provide more data, and hope that pp405 could enhance hair transplant outcomes.

The user has been using dutasteride twice a week for 8 months and oral minoxidil for 3 months but is experiencing increased hair thinning. Many recommend taking dutasteride daily for improved results.

Finasteride can effectively slow or halt hair loss, even for those genetically predisposed to significant balding, like Norwood 6 or 7. Many users report long-term maintenance or improvement, often combining it with other treatments like Dutasteride or Minoxidil for better results.

Pelage Pharmaceutical raised $120 million to continue research on PP405, a promising hair loss treatment that showed a 20% increase in hair density in 31% of men during a Phase 2a trial. The treatment was well-tolerated, with no systemic absorption, and Phase 3 trials are planned for 2026.

Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.

The user experienced initial improvement in hair loss with oral finasteride and minoxidil but later faced increased shedding and thinning. They switched to dutasteride, hoping for better results, while continuing topical minoxidil.

A 31-year-old man with androgenic alopecia is considering treatments like finasteride, minoxidil, and ketoconazole shampoo but is worried about finasteride's side effects. Users recommend starting with finasteride or dutasteride for DHT blocking, suggesting topical solutions to reduce side effects.

The user experienced decreased libido with saw palmetto and is now considering topical anti-androgens like RU58841, pyrilutamide, and topical dutasteride for hair loss. Minoxidil is also mentioned as a potential addition, but the user is cautious about side effects and availability of treatments.

A 22-year-old is considering starting finasteride for hair loss, questioning if their hairline is stable or if treatment is needed. They shared images of their hairline, which has been the same since their teenage years.

Hair loss treatments like Minoxidil, finasteride, and stem cell therapies exist, but a complete cure is hindered by genetic complexity and market dynamics. Cloning hair follicles is considered a potential solution, but it's currently not feasible.

The conversation is about a user sharing their progress with hair loss treatment using 2.5 mg oral finasteride and a 5% minoxidil spray, encouraging others to stay consistent. The user noticed results in mid-August and has not experienced side effects, despite the high dosage of finasteride.

Some embrace baldness, while others promote treatments like minoxidil and finasteride. Opinions differ on accepting baldness versus pursuing hair regrowth.

Switching generic finasteride manufacturers can reduce side effects while maintaining effectiveness. Different fillers in generics may affect bioavailability and cause varying side effects.

The conversation is about hair loss treatments, focusing on finasteride and minoxidil. Users suggest combining these with microneedling, but some recommend a hair transplant due to significant hair loss.

A user is starting a hair loss treatment with a 3-in-1 spray containing 6% minoxidil, 0.3% finasteride, and 0.025% tretinoin. Users are skeptical about its effectiveness due to advanced hair loss, but some suggest adding microneedling and using affordable generics.

The conversation humorously suggests that the hair loss industry, referred to as "Big Bald," deliberately delays a cure to profit from ongoing treatments like minoxidil, finasteride, and dutasteride. Participants debate whether a cure would be more profitable than current treatments, with some suggesting that the industry prefers continuous treatments for sustained profit.